The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC
- DOI
- 10.3390/biomedicines14091882
- Published
- 2026-08-24
- Container
- Biomedicines
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14091882,
title = {The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC},
author = {Noa Shani Shrem and Samer Abu-Rafe and Abed Agbarya and Ashraf Abu Jama and Asmah Miari and Ronen Brenner and Yulia Dudnik and Adan Khalaily and Alexander Yakobson and Samer Hussany and Raya Bdair and Keren Rouvinov and Nashat Abu Yasin and Natalie Maimon Rabinovich and Walid Shalata},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14091882},
url = {https://doi.org/10.3390/biomedicines14091882}
}RIS
TY - JOUR TI - The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC AU - Noa Shani Shrem AU - Samer Abu-Rafe AU - Abed Agbarya AU - Ashraf Abu Jama AU - Asmah Miari AU - Ronen Brenner AU - Yulia Dudnik AU - Adan Khalaily AU - Alexander Yakobson AU - Samer Hussany AU - Raya Bdair AU - Keren Rouvinov AU - Nashat Abu Yasin AU - Natalie Maimon Rabinovich AU - Walid Shalata PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14091882 UR - https://doi.org/10.3390/biomedicines14091882 ER -
APA
Shrem, N. S., Abu-Rafe, S., Agbarya, A., Jama, A. A., Miari, A., Brenner, R., Dudnik, Y., Khalaily, A., Yakobson, A., Hussany, S., Bdair, R., Rouvinov, K., Yasin, N. A., Rabinovich, N. M., & Shalata, W. (2026). The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC. Biomedicines. https://doi.org/10.3390/biomedicines14091882
Source records
- crossref · retrieved 2026-09-26T18:25:21.573Z